Regulus Therapeutics Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Regulus Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2011 to Q3 2024.
  • Regulus Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.42M, a 149% increase year-over-year.
  • Regulus Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.31M, a 192% increase year-over-year.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.8M, a 28.7% increase from 2022.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.18M, a 25.5% decline from 2021.
  • Regulus Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.92M, a 11.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.31M $2.42M +$1.45M +149% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.86M $1.87M +$1.48M +388% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.38M $985K +$575K +140% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.8M $1.04M +$640K +162% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $2.16M $973K +$613K +170% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.55M $382K -$39K -9.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.59M $410K -$590K -59% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.18M $396K -$275K -41% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.45M $360K -$447K -55.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.9M $421K -$333K -44.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.23M $1M +$309K +44.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.92M $671K +$201K +42.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $2.72M $807K +$115K +16.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.61M $754K +$125K +19.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.48M $691K -$132K -16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $2.61M $470K -$4K -0.84% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $2.62M $692K +$156K +29.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.46M $629K +$310K +97.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.15M $823K -$136K -14.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.29M $474K -$1.58M -76.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $3.87M $536K +$136K +34% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.73M $319K -$1.04M -76.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $4.77M $959K -$668K -41.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $5.44M $2.06M +$944K +84.9% Oct 16, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $400K -$884K -68.8% Oct 15, 2018 10-K 2020-03-12
Q3 2018 $4.5M $1.39M +$106K +8.26% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $5.38M $1.36M -$1.51M -52.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $6.89M $1.63M -$754K -31.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $7.64M $1.11M -$2.31M -67.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $9.95M $1.28M -$2.18M -63% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $12.1M $2.87M +$627K +28% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $11.5M $2.38M -$1.37M -36.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $12.9M $3.42M -$344K -9.14% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $13.2M $3.47M +$833K +31.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $12.4M $2.24M -$3.63M -61.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $16M $3.75M +$646K +20.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $15.4M $3.76M +$1.43M +61.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $13.9M $2.63M +$1.01M +61.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $12.9M $5.87M +$4.19M +249% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $8.74M $3.1M +$1.7M +122% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $7.04M $2.33M +$1.43M +159% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 $5.61M $1.63M +$649K +66.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $4.96M $1.68M +$925K +122% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $4.04M $1.4M +$613K +77.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $3.42M $898K +$80K +9.78% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 $3.34M $978K +$564K +136% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $2.78M $759K +$554K +270% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.22M $787K +$674K +596% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $1.55M $818K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $414K +$218K +111% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $205K Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-16
Q1 2012 $113K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $196K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.